Immunoassay Market size to increase by USD 9.4 Billion between 2024 to 2029, Market Segmentation by Product, Technology, Geography , Technavio
NEW YORK, Jan. 10, 2025 /PRNewswire/ -- The global immunoassay market size is estimated to grow by USD 9.4 billion from 2025 to 2029, according to Technavio. The market is estimated to grow at a CAGR of 4.6% during the forecast period. The report provides a comprehensive forecast of key segments below-
Segmentation Overview
- 1.1 Reagents and kits
- 1.2 Analyzers
- 2.1 ELISA
- 2.2 Radioimmunoassay (RIA)
- 2.3 Others
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
Get a glance at the market contribution of rest of the segments - Download a FREE Sample Report in minutes!
1.1 Fastest growing segment:
Immunoassays are essential diagnostic tools that rely on reagents to facilitate reactions and optimize performance. Reagents, which include antigens, antibodies, and buffers, play a crucial role in addressing technical challenges such as non-specific binding and matrix interferences. They ensure protein activity and longer shelf life, ultimately improving assay performance and reducing the need for additional resources. Despite the convenience of assay kits, not all offer the required sensitivity and reproducibility for extensive research. This gap in the market is expected to fuel demand for high-performing reagents and drive growth in the immunoassay market during the forecast period. Compatibility with analyzer materials is also a critical consideration to prevent any damage to the instrument components.
Analyst Review
The Immunoassay market refers to the diagnostic testing segment of medical technology that utilizes laboratory equipment to perform various types of immunochemical assays for the detection of biomarkers. These analytical methods include antibody-based assays such as fluorescence immunoassays, chemiluminescent immunoassays, radioimmunoassays, lateral flow assays, immunofluorescence assays, and multiplex assays. Immunoassays are used for clinical diagnostics in various fields, including infectious disease testing, cancer biomarkers, autoimmune disease testing, allergy testing, therapeutic drug monitoring, oncology, cardiology, and neurology. Immunoassay kits and diagnostic reagents are essential components of these tests, along with biosensors and microfluidic devices. Protein detection is a significant application of immunoassays, with hormone assays being a common example. Immunoassays offer rapid and sensitive results, making them valuable tools in healthcare and research settings.
Market Overview
The Immunoassay market refers to the diagnostic testing segment of medical technology that utilizes immunochemical techniques for the quantitative or qualitative detection of biomolecules, primarily proteins and antigens, in various samples. Immunoassays are essential tools in clinical diagnostics, research laboratories, and pharmaceutical industries for the detection of biomarkers in areas such as infectious diseases, autoimmune diseases, oncology, neurology, hormone assays, and therapeutic drug monitoring. Immunoassay technologies include analytical methods like fluorescence immunoassays, chemiluminescent immunoassays, radioimmunoassays, lateral flow assays, immunofluorescence assays, multiplex assays, and biosensors. Immunoassay platforms, such as clinical laboratories and research laboratories, employ assay development, validation, optimization, and automation for improving immunoassay sensitivity, specificity, performance, accuracy, precision, and reliability. Immunoassays are crucial for precision medicine and the discovery of new biomarkers in various therapeutic areas.
To understand more about this market- Download a FREE Sample Report in minutes!
Key Topics Covered: 1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Venodr Landscape
11 Vendor Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/immunoassay-market-size-to-increase-by-usd-9-4-billion-between-2024-to-2029--market-segmentation-by-product-technology-geography---technavio-302346909.html
SOURCE Technavio